ARTICLE | Management Tracks
Plus: Zheng joins HBM and Nobias names Dougherty CEO
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
November 16, 2024 12:13 AM UTC
OMass Therapeutics Ltd. named Steven Charlton CSO. Charlton joined OMass in 2020 as VP of pharmacology; he’s also a professor at the University of Nottingham. OMass is using its mass spectrometry platform to discover small molecules against difficult-to-drug targets.
HBM Holdings Ltd. (HKEX:02142) hired Raymond Zheng as CBO. Zheng was interim CEO and CSO of Urica Therapeutics Inc., a company he co-founded…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654226/charlton-becomes-cso-of-omass